Investing Profile

Peter Barrett

Photo of Peter Barrett, Partner at Atlas Venture

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$500K - $5.0M
$2.0M
28
CompanyStageDateRound SizeTotal Raised
Obsidian Therapeutics
Series BSep 2021$120M
Series ADec 2017$50M
$170M
Cadent Therapeutics
Series BApr 2020$15M
Series BNov 2018$40M
Series AJun 2013$6M
$61M
Indalo Therapeutics
Series UnknownAug 2017$9M
$9M
Co-investors: Ben Auspitz (F-Prime Capital Partners)
Synlogic
Series CMay 2017$42M
Series BFeb 2016$40M
Series AOct 2014$5M
Series AJul 2014$29M
$120M
Co-investors: Ed Mathers (New Enterprise Associates (NEA)), Daphne Teo (Nest.Bio Labs)
DeepScale
SeedMar 2017$3M
$19M
Co-investors: Jerry Chen (Greylock), Robert Pollak (SV Angel), Jerry Yang (AME Cloud Ventures), Alex Ferrara (Bessemer Venture Partners), Lip-Bu Tan (Walden International), Ali Partovi (Neo), Jory Bell (Playground Global), Albert Azout (Cota Capital), Jerry Yang (Hardware Club), Quin Garcia (Autotech Ventures), TJ Rylander (Next47), Sri Chandrasekar (Point72 Ventures), Andy Chou (11.2 Capital), Steve Blank (M34 Capital), Jerry Fiddler, Hadi Partovi
JenaValve Technology
Series CAug 2015$27M
Series CApr 2014$10M
Series CJul 2013$63M
Series BJun 2010$23M
$270M
Co-investors: Olivier Litzka (Andera Partners), Andrew Hack (Bain Capital Life Sciences)
Raze Therapeutics
Series AOct 2014$24M
$24M
Co-investors: Ansbert Gadicke (MPM Capital), Reza Halse (RA Capital), Hakan Goker (M Ventures (Merck)), Jason Rhodes (Atlas Venture)
Harbour Antibodies
Series AJul 2013$3M
$3M